1. Home
  2. CRVS vs VPG Comparison

CRVS vs VPG Comparison

Compare CRVS & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • VPG
  • Stock Information
  • Founded
  • CRVS 2014
  • VPG 2009
  • Country
  • CRVS United States
  • VPG United States
  • Employees
  • CRVS N/A
  • VPG N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • VPG Electrical Products
  • Sector
  • CRVS Health Care
  • VPG Technology
  • Exchange
  • CRVS Nasdaq
  • VPG Nasdaq
  • Market Cap
  • CRVS 459.0M
  • VPG 427.5M
  • IPO Year
  • CRVS 2016
  • VPG N/A
  • Fundamental
  • Price
  • CRVS $8.04
  • VPG $37.46
  • Analyst Decision
  • CRVS Strong Buy
  • VPG
  • Analyst Count
  • CRVS 4
  • VPG 0
  • Target Price
  • CRVS $13.75
  • VPG N/A
  • AVG Volume (30 Days)
  • CRVS 1.1M
  • VPG 141.2K
  • Earning Date
  • CRVS 11-04-2025
  • VPG 11-04-2025
  • Dividend Yield
  • CRVS N/A
  • VPG N/A
  • EPS Growth
  • CRVS N/A
  • VPG N/A
  • EPS
  • CRVS N/A
  • VPG N/A
  • Revenue
  • CRVS N/A
  • VPG $295,282,000.00
  • Revenue This Year
  • CRVS N/A
  • VPG N/A
  • Revenue Next Year
  • CRVS N/A
  • VPG $5.40
  • P/E Ratio
  • CRVS N/A
  • VPG N/A
  • Revenue Growth
  • CRVS N/A
  • VPG N/A
  • 52 Week Low
  • CRVS $2.54
  • VPG $18.57
  • 52 Week High
  • CRVS $10.00
  • VPG $38.90
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 64.17
  • VPG 60.16
  • Support Level
  • CRVS $7.46
  • VPG $35.51
  • Resistance Level
  • CRVS $7.96
  • VPG $38.90
  • Average True Range (ATR)
  • CRVS 0.56
  • VPG 1.99
  • MACD
  • CRVS 0.01
  • VPG 0.14
  • Stochastic Oscillator
  • CRVS 75.46
  • VPG 78.60

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

Share on Social Networks: